A detailed history of Summit Financial, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Summit Financial, LLC holds 31,544 shares of PFE stock, worth $843,486. This represents 0.04% of its overall portfolio holdings.

Number of Shares
31,544
Previous 29,446 7.12%
Holding current value
$843,486
Previous $823,000 10.81%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $58,114 - $65,856
2,098 Added 7.12%
31,544 $912,000
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $371,397 - $435,208
14,703 Added 99.73%
29,446 $823,000
Q1 2024

Apr 24, 2024

SELL
$25.89 - $29.73 $36,220 - $41,592
-1,399 Reduced 8.67%
14,743 $409,000
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $27,619 - $35,874
-1,057 Reduced 6.15%
16,142 $464,000
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $119,406 - $139,574
3,721 Added 27.61%
17,199 $570,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $108,323 - $125,328
2,999 Added 28.62%
13,478 $494,000
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $1,260 - $1,640
-32 Reduced 0.3%
10,479 $427,000
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $80,201 - $104,694
-1,921 Reduced 15.45%
10,511 $538,000
Q3 2022

Nov 15, 2022

SELL
$43.76 - $53.42 $650,536 - $794,141
-14,866 Reduced 54.46%
12,432 $544 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $27,452 - $32,550
-590 Reduced 2.12%
27,298 $1.43 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $562,908 - $697,513
12,304 Added 78.95%
27,888 $1.44 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $100,903 - $149,572
2,442 Added 18.58%
15,584 $920,000
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $174,819 - $224,570
4,454 Added 51.27%
13,142 $565,000
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $311,986 - $353,427
8,688 New
8,688 $340,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Summit Financial, LLC Portfolio

Follow Summit Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.